Accessibility Menu
 

Why Exact Sciences Fell 18% in September and Continues to Drop in October

Exact Sciences shares are falling sharply on worries that demand for its colon cancer-screening test will fall shy of predictions.

By Todd Campbell Oct 9, 2015 at 5:01PM EST

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.